mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |